Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 5/20 | 0.56 |
| ▸ | MGAM | O43451 | 4/20 | 0.56 |
| ▸ | SI | P14410 | 4/20 | 0.56 |
| ▸ | MGAM2 | Q2M2H8 | 4/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | HTR7 | P34969 | 1/20 | 0.44 |
| ▸ | HTR6 | P50406 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | PIM1 | P11309 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CCKBR | P32239 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11897128 | 0.79 | GAA (0.54) | GAAMGAMSIMGAM2HTR1A | |
| SCHEMBL17867081 | 0.76 | GAA (0.45) | GAAMGAMSIMGAM2HTR1A | |
| SCHEMBL11897095 | 0.76 | MGAM (0.44) | GAAMGAMSIMGAM2HTR1A | |
| SCHEMBL30870404 | 0.73 | MGAM (1.00) | GAAMGAMSIMGAM2HTR1A | |
| SCHEMBL20550167 | 0.73 | MGAM (1.00) | GAAMGAMSIMGAM2HTR1A | |
| SCHEMBL29628076 | 0.71 | PIM1 (0.71) | GAAMGAMSIMGAM2HTR1A | |
| SCHEMBL5435863 | 0.71 | PIM1 (0.71) | GAAMGAMSIMGAM2HTR1A | |
| SCHEMBL29365030 | 0.69 | IDO1 (0.60) | GAAIDO1LMNAALDH1A1PDK2 | |
| SCHEMBL15499981 | 0.69 | PDK2 (0.50) | GAAIDO1LMNAALDH1A1MAPT | |
| SCHEMBL29439898 | 0.69 | GAA (0.55) | GAAMGAMSIMGAM2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2650274-B1 | A thionation process and a thionating agent | VIRONOVA THIONATION AB (SE) | 2019-05-01 | — | — | EP | disclosed |
| US-9221855-B2 | Thionation process and a thionating agent | VIRONOVA THIONATION AB (SE) | 2015-12-29 | — | — | US | disclosed |
| US-9115158-B2 | Thionating agent | VIRONOVA THIONATION AB (SE) | 2015-08-25 | — | — | US | disclosed |
| US-20130303767-A1 | THIONATING AGENT | VIRONOVA THIONATION AB (SE) | 2013-11-14 | — | — | US | disclosed |
| EP-2569263-B1 | A THIONATION PROCESS AND A THIONATING AGENT | VIRONOVA AB (SE) | 2013-11-13 | — | — | EP | disclosed |
| EP-2650274-A2 | A thionation process and a thionating agent | Vironova AB (SE) | 2013-10-16 | — | — | EP | disclosed |
| US-20130102774-A1 | THIONATION PROCESS AND A THIONATING AGENT | VIRONOVA AB (SE) | 2013-04-25 | — | — | US | disclosed |
| EP-2569263-A1 | A THIONATION PROCESS AND A THIONATING AGENT | Vironova AB (SE) | 2013-03-20 | — | — | EP | disclosed |
| WO-2012104415-A1 | A THIONATION PROCESS AND A THIONATING AGENT | VIRONOVA AB (SE) | 2012-08-09 | — | — | WO | disclosed |
| EP-2484655-A1 | A thionation process and a thionating agent | Vironova AB (SE) | 2012-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130102774-A1 | THIONATION PROCESS AND A THIONATING AGENT | NT5M, NT5E, NUDT5 | GAA 4143/4885MGAM 2016/4885SI 1831/4885 |
| US-20130303767-A1 | THIONATING AGENT | NT5E, NT5C2, NUDT5 | GAA 4042/4885MGAM 2542/4885SI 2536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.